Skip to content

Clinical trials

Observational Multiple Sclerosis trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Phase: Observational Country / region: United Kingdom Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20074
20091
20101
20113
20123
20132
20142
20152
20161
20173
20183
20195
20203
20217
20224
20236
20243
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Unknown status7
Recruiting5
Active, not recruiting4
Enrolling by invitation3
Terminated2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen8
Nottingham University Hospitals NHS Trust5
Merck KGaA, Darmstadt, Germany3
Queen Mary University of London3
University of Edinburgh3
University of Exeter3
Bayer2
East Kent Hospitals University NHS Foundation Trust2
King's College London2
Novartis Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis56
Multiple Sclerosis, Relapsing-Remitting5
Parkinson Disease4
Stroke4
COVID-193
Amyotrophic Lateral Sclerosis2
Anxiety Disorders2
Arthritis2
Arthritis, Rheumatoid2
Asthma2

Trials

Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.